Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nazir Ismail

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
PLOS Global Public Health|March 31, 2023
Updating the WHO target product profile for next-generation Mycobacterium tuberculosis drug susceptibility testing at peripheral centresEmily Lai-Ho MacLean, Paolo Miotto, Lice González Angulo, et al.
Open Forum Infectious Diseases|August 31, 2017
The Burden and Clinical Presentation of Pulmonary Tuberculosis in Adults With Severe Respiratory Illness in a High Human Immunodeficiency Virus Prevalence Setting, 2012-2014Sibongile Walaza, Stefano Tempia, Andries Dreyer, et al.
The Lancet. Infectious Diseases|June 1, 2026
Future-proofing tuberculosis therapy: framework for concurrent drug and resistance testing developmentFrancesca Saluzzo, Seda Yerlikaya, Susan Elizabeth Dorman, et al.
The European Respiratory Journal|October 27, 2018
High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimenNorbert Ndjeka, Kathryn Schnippel, Iqbal Master, et al.
Open Forum Infectious Diseases|March 26, 2019
The Impact of Influenza and Tuberculosis Interaction on Mortality Among Individuals Aged ≥15 Years Hospitalized With Severe Respiratory Illness in South Africa, 2010-2016Sibongile Walaza, Stefano Tempia, Halima Dawood, et al.
PLOS Global Public Health|October 14, 2024
Systematic review of the economic impact of novel Mycobacterium tuberculosis specific antigen-based skin tests for detection of TB infection compared with tuberculin skin test and interferon-gamma release assaysLara Goscé, Kasim Allel, Yohhei Hamada, et al.
American Journal of Epidemiology|April 4, 2020
Modeling Missing Cases and Transmission Links in Networks of Extensively Drug-Resistant Tuberculosis in KwaZulu-Natal, South AfricaKristin N Nelson, Neel R Gandhi, Barun Mathema, et al.
Antimicrobial Agents and Chemotherapy|November 5, 2014
Evaluation of pyrosequencing for detecting extensively drug-resistant Mycobacterium tuberculosis among clinical isolates from four high-burden countriesKanchan Ajbani, Shou-Yean Grace Lin, Camilla Rodrigues, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 26, 2019
Social Mixing and Clinical Features Linked With Transmission in a Network of Extensively Drug-resistant Tuberculosis Cases in KwaZulu-Natal, South AfricaKristin N Nelson, Samuel M Jenness, Barun Mathema, et al.
Plos Medicine|January 22, 2020
Prevalence and genetic profiles of isoniazid resistance in tuberculosis patients: A multicountry analysis of cross-sectional dataAnna S Dean, Matteo Zignol, Andrea Maurizio Cabibbe, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
PLOS Global Public Health|March 31, 2023
Updating the WHO target product profile for next-generation Mycobacterium tuberculosis drug susceptibility testing at peripheral centresEmily Lai-Ho MacLean, Paolo Miotto, Lice González Angulo, et al.
Open Forum Infectious Diseases|August 31, 2017
The Burden and Clinical Presentation of Pulmonary Tuberculosis in Adults With Severe Respiratory Illness in a High Human Immunodeficiency Virus Prevalence Setting, 2012-2014Sibongile Walaza, Stefano Tempia, Andries Dreyer, et al.
The Lancet. Infectious Diseases|June 1, 2026
Future-proofing tuberculosis therapy: framework for concurrent drug and resistance testing developmentFrancesca Saluzzo, Seda Yerlikaya, Susan Elizabeth Dorman, et al.
The European Respiratory Journal|October 27, 2018
High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimenNorbert Ndjeka, Kathryn Schnippel, Iqbal Master, et al.
Open Forum Infectious Diseases|March 26, 2019
The Impact of Influenza and Tuberculosis Interaction on Mortality Among Individuals Aged ≥15 Years Hospitalized With Severe Respiratory Illness in South Africa, 2010-2016Sibongile Walaza, Stefano Tempia, Halima Dawood, et al.
PLOS Global Public Health|October 14, 2024
Systematic review of the economic impact of novel Mycobacterium tuberculosis specific antigen-based skin tests for detection of TB infection compared with tuberculin skin test and interferon-gamma release assaysLara Goscé, Kasim Allel, Yohhei Hamada, et al.
American Journal of Epidemiology|April 4, 2020
Modeling Missing Cases and Transmission Links in Networks of Extensively Drug-Resistant Tuberculosis in KwaZulu-Natal, South AfricaKristin N Nelson, Neel R Gandhi, Barun Mathema, et al.
Antimicrobial Agents and Chemotherapy|November 5, 2014
Evaluation of pyrosequencing for detecting extensively drug-resistant Mycobacterium tuberculosis among clinical isolates from four high-burden countriesKanchan Ajbani, Shou-Yean Grace Lin, Camilla Rodrigues, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 26, 2019
Social Mixing and Clinical Features Linked With Transmission in a Network of Extensively Drug-resistant Tuberculosis Cases in KwaZulu-Natal, South AfricaKristin N Nelson, Samuel M Jenness, Barun Mathema, et al.
Plos Medicine|January 22, 2020
Prevalence and genetic profiles of isoniazid resistance in tuberculosis patients: A multicountry analysis of cross-sectional dataAnna S Dean, Matteo Zignol, Andrea Maurizio Cabibbe, et al.
Pageof 8